Ceramic module emitting far infrared radiation and specific low dose ionizing radiation
This invention relates to a ceramic module for assembly into a therapeutic device for treating a human or animal body with irradiation of far infrared radiation and low dose ionizing radiation based on radiation hormesis effect. More specifically, the invention relates to a ceramic module that simultaneously emits far infrared radiation within 3-16 μm wavelength spectrum and ionizing radiation at a specific dose rate in the range of 0.1-11 μSv/h (micro-Sieverts per hour). Said ceramic module may be used alone or serve as components of a therapeutic device for increasing physiologic performance, immune competence, health, and mean lifespan of human or animal.
1. A ceramic module for use in a therapeutic device for treating a human or animal body, said ceramic module comprising a mixture of a first set of powdered substance emitting far infrared radiation and a second set of powdered substance emitting ionizing radiation, wherein as a result of the mixture of the first and second sets of powdered substances being calcined at a temperature at or above 900° C. into a shaped article comprising at least one dipole crystalline region and at least one amorphous region, said ceramic module simultaneously emits far infrared radiation within 3-16 μm wavelength spectrum and ionizing radiation at a specific dose rate in the range of 0.1-11 μSv/h.
2. The ceramic module according to claim 1 , wherein the ionizing radiation dose rate of said ceramic module is in the range of 0.1-0.5 μSv/h.
3. The ceramic module according to claim 1 , wherein said first set of powdered substance includes one or more oxides selected from the group consisting of silicate, alumina, zirconia, phosphate, sodium oxide, potassium oxide, ferric oxide, chromic oxide, titanium oxide, magnesium oxide, manganese oxide, calcium oxide, nickel oxide, and cobalt oxide, wherein at least one of the selected oxides is at least 2% by weight of the first set of powdered substance.
4. The ceramic module according to claim 1 , wherein said first set of powdered substance includes approximately 5-30% by weight of tourmaline.
5. The ceramic module according to claim 1 , wherein said second set of powdered substance includes at least one radioactive isotope of uranium, thorium, potassium, cobalt, or radium.
6. The ceramic module according to claim 1 , wherein said second set of powdered substance includes at least one oxide containing a radioactive isotope of uranium, thorium, potassium, cobalt, or radium.
7. The ceramic module according to claim 1 , wherein said second set of powdered substance includes at least one mineral containing a radioactive isotope of uranium, thorium, potassium, cobalt, or radium.
8. The ceramic module according to claim 7 , wherein the at least one mineral is thorite or uraninite.
9. The ceramic module according to claim 7 , wherein the at least one mineral is thorium-rich monazite.
10. The ceramic module according to claim 9 , wherein said thorium-rich monazite contains 6-12% thorium oxide.
11. The ceramic module according to claim 1 , wherein said ceramic module is rectangular, circular, cylindrical, or spherical in shape.
12. The ceramic module according to claim 1 , wherein said ceramic module is mounted on a flexible substrate for attaching to a body part to be treated.